Arcus Biosciences, Inc.RCUSNYSE
Loading
SG&A Expenses Over TimeStrong
Percentile Rank78
3Y CAGR+1.9%
5Y CAGR+20.7%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+1.9%/yr
vs +66.4%/yr prior
5Y CAGR
+20.7%/yr
Recent deceleration
Acceleration
-64.5pp
Decelerating
Percentile
P78
Within normal range
vs 5Y Ago
2.6x
Strong expansion
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
TTM$110.00M-8.3%
2024$120.00M+2.6%
2023$117.00M+12.5%
2022$104.00M+44.4%
2021$72.00M+67.4%
2020$43.00M+70.4%
2019$25.23M+86.0%
2018$13.57M+77.7%
2017$7.64M+94.1%
2016$3.94M-